Cytotoxicity and effects on inflammatory response of modified types of cellulose in macrophage-like THP-1 cells

International Immunopharmacology

Volumn 11, Issue 8, 2011, Pages 997-1001

  Kollar, Peter ^a   Závalová, Veronika ^a   Hošek, Jan ^a   Havelka, Pavel ^b   Sopuch, Tomáš ^c   Karpíšek, Michal ^a   Třetinová, Dominika ^a   Suchý Jr , Pavel ^a  

^a UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^b Research Institute for Organic Syntheses   (Czech Republic)

^c Synthesia As   (Czech Republic)

Author keywords

Cellulose; Inflammation; Macrophages; THP 1 cells; Tumor necrosis factor

Indexed keywords

CARBOXYMETHYLCELLULOSE; CELLULOSE; DIALDEHYDE CELLULOSE; MICROCRYSTALLINE CELLULOSE; MICROFIBRILATED CELLULOSE; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; WOUND HEALING;

EID: 84860389832     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.02.016     Document Type: Article

References (21)

1. Ryšavá J, Dyr JE, Homola J, Dostálek J, Krížová P, Mášová L, et al. Surface interactions of oxidized cellulose with fibrin(ogen) and blood platelets. Sens Actuators B Chem 2003;90:243-9.
2. Belozerskaya GG, Makarov VA, Zhidkov EA, Malykhina LS, Sergeeva OA, Ter- Arutyunyants AA, et al. Local hemostatics (A review). Pharm Chem J 2006;40: 353-9. (Pubitemid 44834304)
3. Schönfelder U, Abel M, Wiegand C, Klemm D, Elsner P, Hipler UC. Influence of selected wound dressings on PMN elastase in chronic wound fluid and their antioxidative potential in vitro. Biomaterials 2005;26:6664-73. (Pubitemid 41021759)
4. Singer AJ, Clark RAF. Cutaneous wound healing. N Engl J Med 1999;341:738-46. (Pubitemid 29407375)
5. James TJ, Hughes MA, Cherry GW, Taylor PT. Evidence of oxidative stress in chronic venous ulcers. Wound Repair Regen 2003;11:172-6. (Pubitemid 36648874)
6. Rasik AM, Shukla A. Antioxidant status in delayed healing type of wounds. Int J Exp Pathol 2000;81:257-63.
7. Hua F, Henstock PV, Tang B. ERK activation by GM-CSF reduces effectiveness of p38 inhibitor on inhibiting TNFalpha release. Int Immunopharmacol 2010;10:730-7.
8. Ardizzone S, Bianchi Porro G. Biologic therapy for inflammatory bowel disease. Drugs 2005;65:2253-86. (Pubitemid 41571985)
9. Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC. Diabetes-enhanced inflammation and apoptosis - impact on periodontal pathology. J Dent Res 2006;85: 15-21. (Pubitemid 43827757)
10. Siqueira MF, Li J, Chehab L, Desta T, Chino T, Krothpali N, et al. Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia 2010;53:378-88.
11. Buck M, Houglum K, Chojkier M. Tumor necrosis factor-alpha inhibits collagen alpha1(I) gene expression and wound healing in a murine model of cachexia. Am J Pathol 1996;149:195-204. (Pubitemid 26230991)
12. Salomon GD, Kasid A, Cromack DT, Director E, Talbot TL, Sank A, et al. The local effects of cachectin/tumor necrosis factor on wound healing. Ann Surg 1991;214: 175-80.
13. Hosek J, Zavalova V, Smejkal K, Bartos M. Effect of diplacone on LPS-induced inflammatory gene expression in macrophages. Folia Biol (Praha) 2010;56:124-30.
14. Glaros T, Larsen M, Li L. Macrophages and fibroblasts during inflammation, tissue damage and organ injury. Front Biosci 2009;14:3988-93.
15. Tesch GH. Role of macrophages in complications of type 2 diabetes. Clin Exp Pharmacol Physiol 2007;34:1016-9. (Pubitemid 47274561)
16. Holtmann MH, Neurath MF. Differential TNF-signaling in chronic inflammatory disorders. Curr Mol Med 2004;4:439-44. (Pubitemid 38787012)
17. Doré M, Sirois J. Regulation of P-selectin expression by inflammatory mediators in canine jugular endothelial cells. Vet Pathol 1996;33:662-71. (Pubitemid 126481309)
18. Fernandez MC, Walters J, Marucha P. Transcriptional and post-transcriptional regulation of GM-CSF-induced IL-1 beta gene expression in PMN. J Leukoc Biol 1996;59:598-603. (Pubitemid 26155303)
19. Gouwy M, Struyf S, Proost P, Van Damme J. Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 2005;16:561-80. (Pubitemid 41505517)
20. Brooks SA, Connolly JE, Diegel RJ, Fava RA, Rigby WF. Analysis of the function, expression, and subcellular distribution of human tristetraprolin. Arthritis Rheum 2002;46:1362-70. (Pubitemid 34525846)
21. Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998;281:1001-5. (Pubitemid 28399252)